OPA1 and prion disease: Our research shows that the protein level of OPA1 is dramatically downregulated in in vitro and in vivo models of prion diseases, and OPA1 overexpression alleviated PrP106–126-induced mitochondrial cristae collapse, mtDNA depletion, mitochondrial dysfunction, and neuronal apoptosis.